Table 2 Clinical profile of T2DM patients grouped by ECG abnormalities using chi-square and student t-test, among selected Referral Hospitals in Amhara National Regional State, Ethiopia, 2021 (n = 258)
Variables | Categories | Total/mean (SD) | ECG abnormality | X2/T-test (p-value) | |
|---|---|---|---|---|---|
Yes (%) | No (%) | Â | |||
Duration of DM (years) |  < 2 | 73(28.2) | 11(4.3) | 62(24) | p < 0.01 |
2–5 | 64(24.8) | 20(7.8) | 44(17) | ||
6–10 | 64(24.8) | 39(15) | 25(9.7) | ||
 > 10 | 57(22.0) | 46(17.) | 11(4.3) | ||
Type of DM drug | No drug | 12(4.6) | 7(2.7) | 5(1.9) | p < 0.001 |
Oral only | 207(80.2) | 99(38.4) | 108(.41.9) | ||
Insulin only | 28(10.9) | 6(2.3) | 22(8.6) | ||
Oral and insulin | 11(4.3) | 6(2.3) | 5(1.9) | ||
History of kidney disease | Yes | 13(5.04) | 11(4.3) | 2(0.7) | p < 0.01 |
No | 245(94.96) | 105(40.7) | 140(54.3) | ||
FBS |  < 130 mg/dl| | 98(37.98) | 14(5.4) | 84(32.6) | p < 0.001 |
≥ 130 mg/dl| | 160(62.02) | 102(39.5) | 58(22.5) | ||
Hypertension | Yes | 109(42.25) | 84(32.6) | 25(9.7) | p < 0.001 |
No | 149(57.75) | 32(12.4) | 117(45.3) | ||
BMI (kg/m2) |  < 25 | 133(51.55) | 32(12.4) | 101(39.1) | p < 0.001 |
25 and above | 125(48.45) | 84(32.6) | 41(15.9) | ||